Objective: To explore the relation between a wide range of alcohol consumptions and levels of the components of insulin-like growth factor system (IGFs) and adiponectin in humans. Design: A cross-sectional study using controls from a case-control study on ovarian and endometrial cancer. Settings: The study included women hospitalized between 1999 and 2002 in Pordenone, Italy. Subjects: One hundred and eight cancer-free (controls) with a median age of 61 years (range 29-79 years), admitted for acute conditions unrelated to gynecologic, hormonal or metabolic disorders or diseases leading to dietary modifications. Interventions: Levels of IGF-I (total and free), total IGF-II, IGF-binding protein 1 (IGFBP-1), IGFBP-3 and adiponectin were individually measured, and their distributions across strata of alcohol consumption were tested by the Kruskal-Wallis statistic. Results: Median concentrations of total IGF-I were higher (Po0.01) in women reporting low (151 ng/ml) or no alcohol consumption (134 ng/ml) compared to drinkers of 12-23 g/day (103 ng/ml) or X24 g/day (118 ng/ml). Median concentrations were higher (P ¼ 0.05) for IGFBP-3 in non-drinkers (2333 ng/ml) and in light drinkers (2647 ng/ml) compared to drinkers of X24 g/day (2090 ng/ml). No statistically significant difference emerged for other IGFs across levels of alcohol intakes. Adiponectin was slightly lower for non-drinkers, compared to all drinkers categories. Conclusions: Our study suggests that alcohol consumption is related to circulating levels of components of the IGF system and adiponectin. These results may have a potential impact on the prevention of several chronic diseases.
Introduction
Several hormones and proteins are involved in energy metabolism and regulation of cell proliferation. In particular, the insulin-like growth factor (IGF) system involves complex regulatory networks that operate at the whole organism, cellular and subcellular levels (Pollak et al., 2004) . Adiponectin is a recently discovered protein with important metabolic effects; it is secreted by adipocytes and acts as an anti-diabetic and anti-atherogenic hormone (Diez and Iglesias, 2003) . Circulating levels of adiponectin are reduced in conditions related to insulin resistance and hyperinsulinemia (Diez and Iglesias, 2003; Dal Maso et al., 2004b) .
Epidemiological evidence is accumulating and suggests that these molecules (insulin-like growth factor system (IGFs) and adiponectin) are related to cell proliferation, obesity, diabetes, hyperinsulinemia and several human malignancies (Yu and Rohan, 2000; Bråkenhielm et al., 2004) . IGF-I, in particular, has been associated with the risk of prostate, breast and colorectal cancers (Kaaks et al., 2000; Sandhu et al., 2002; Renehan et al., 2004) . IGF-binding protein 3 (IGFBP-3) has been also positively related to breast cancer, in premenopausal women, and to colorectal cancer (Kaaks et al., 2000) , but IGFBP-3 was inversely related to ovarian cancer (Dal Maso et al., 2004a) . IGFBP-1 was directly related with ovarian (Dal Maso et al., 2004a) and, possibly, endometrial cancer (Augustin et al., 2004) , whereas an inverse association emerged with colorectal cancer (Kaaks et al., 2000) . An inverse association with endometrial (Petridou et al., 2003; Dal Maso et al., 2004b) and breast cancer (Mantzoros et al., 2004) risk emerged for plasma adiponectin.
Only limited information is available on the biological mechanisms and interactions between IGF components, adiponectin and other cancer risk factors (e.g., alcohol) involved in insulin stimulation and energy metabolism (Röjdmark et al., 2000; Yu and Rohan, 2000; Moschos and Mantzoros, 2002; Pollak et al., 2004; Sierksma et al., 2004) .
The relation between alcohol consumption and IGF levels is unclear. Different levels of alcohol consumption may have opposite effects on IGF levels (Yu and Rohan, 2000) . Recently, Lavigne et al. (2005) reported alcohol to be negatively related to IGF-I and, nonsignificantly, to IGFBP-3, in postmenopausal women. However, other findings on this topic have revealed inconsistent results (GoodmanGruen and Barrett-Connor, 1997; Röjdmark et al., 2000; Holmes et al., 2002; Lavigne et al., 2004) . A few recent studies showed that a moderate alcohol consumption increased plasma adiponectin level (Shai et al., 2004; Sierksma et al., 2004; Thamer et al., 2004) .
To provide further evidence on the possible effect of a wide range of alcohol consumption on several components of the IGF system and adiponectin, we examined the information available on women enrolled as controls in a case-control study on ovarian and endometrial cancer. The study was conducted between 1999 and 2002 in the province of Pordenone, Italy, where alcohol consumption among women is wide spread and relatively high.
Subjects and methods
This was a cross-sectional investigation based on the comparison group of a case-control study. The methods of the original case-control study were described previously (Augustin et al., 2004; Dal Maso et al., 2004b) . Subjects included in the present report were 108 controls (i.e., cancerfree women) aged 29-79 years (median 61 years). Most of them (80, 76%) were postmenopausal women, admitted for acute non-neoplastic conditions unrelated to gynecologic, hormonal, metabolic disorders or to dietary modifications. Eighty-seven percent of subjects were admitted to an orthopedic department and 13% to other departments for miscellaneous illnesses such as eye, ear, nose or throat disorders. Women with diabetes mellitus were excluded. Two eligible patients declined the interviewed.
Trained interviewers collected information on sociodemographic and behavioral characteristics. Weekly number of drinks (i.e., average over the year before interview) for several alcoholic beverages was elicited from the subjects. Taking into account the different ethanol concentrations, one drink corresponded to approximately 125 ml of wine, 330 ml of beer and 30 ml of hard liquor (i.e., approximately 12-15 g of ethanol). Total alcohol intake, expressed in grams per day (g/day), was the sum of all alcoholic beverages reported. In this population, approximately 90% of alcohol intake is due to wine consumption. Never drinkers were patients who had abstained from drinking lifelong. Five women abstaining from drinking for at least 12 months at the time of interview were considered former drinkers and included in the 'nondrinkers' category.
Interviews and blood collections were conducted on the first day of hospitalization and each woman provided a 15-ml sample of blood, usually on the same day of the interview. Blood samples were kept refrigerated and processed, within 12 h from collection, at the National Cancer Institute, Aviano. They were centrifuged at 1500 r.p.m. for 20 min, stored at À801C and sent to the Department of Nutritional Sciences, University of Toronto, Canada (Augustin et al., 2004; Dal Maso et al., 2004a) . The IGF components were analyzed in ethylenediaminetetraacetic acid plasma samples by means of enzyme-linked immunosorbent assay (ELISA) (Diagnostic System Laboratories (DSL), Webster, TX, USA). Free IGF-I was assessed using DSL-10-9400 with a sensitivity of 0.015 ng/ml; DSL-10-2800 with a sensitivity of 0.01 ng/ml was used for total IGF-I; DSL-10-2600 with a sensitivity of 2.2 ng/ml for IGF-II; and DSL-10-6600 with a sensitivity of 0.04 ng/ml for IGFBP-3. ELISA kit (Alpha Diagnostic, San Antonio, TX, USA, catalog no. 0900) with a sensitivity of 0.4 ng/ml was used to assess IGFBP-1. All assays were run in duplicates with an average intra-assay variation coefficient of o8% (Dal Maso et al., 2004a) . Adiponectin analysis was blindly performed at the Human Nutritional Research Unit, Harvard Medical School (Boston, MA, USA), by means of a radioimmunoassay with a sensitivity of 2 ng/ml, and intra-assay coefficient of variation of 8% (Dal Maso et al., 2004b) .
For IGFs and adiponectin, median and interquartile ranges were calculated and Kruskal-Wallis test performed. The test is the non-parametric version of one-way analysis of variance and a generalization of the Wilcoxon test for two independent samples. In presence of some independent samples, all the samples were combined into a larger one, the results sorted from smallest to largest, and the ranks assigned. Finally, the average of the observation ranks was derived within the sample.
Results
Selected characteristics of the 108 subjects included in the data analysis are given in Table 1 . Approximately half (56%) of study participants were overweight (body mass index (BMI) X25 kg/m 2 ), and 16 (15%) were obese (BMI X30 kg/m 2 ). In this study, the range of median values of IGF components and adiponectin varied widely (Table 1) . Table 2 shows the median plasma levels of adiponectin and several components of the IGF system in four categories of alcohol level: 0, 1-11 12-23 and X24 g/day. Median concentrations of total IGF-I were higher in women reporting low (151 ng/ml) or no alcohol consumption (134 ng/ml) compared to drinkers of 12-23 g/day (103 ng/ml) or X24 g/day (118 ng/ml) with significantly heterogeneous distributions across strata (Kruskal-Wallis Po0.01), but no significant linear trend. Median concentration was also higher for IGFBP-3 in non-drinkers and in low drinkers (2333 and 2647 ng/ml, respectively) compared to drinkers of X24 g/day (2090 ng/ml). As a consequence of the concurrent decrease of total IGF-I and IGFBP-3 across increasing intakes of alcohol, the ratio of IGF-I to IGFBP-3 and the bioavailable free IGF-I were similar in different strata. No statistically significant difference emerged for total IGF-II and IGFBP-1 for which a wide individual variability emerged.
Median plasma adiponectin level was 13.3 mg/ml for nondrinkers, and it was slightly higher in all drinkers' categories (i.e., 17.4, 15.2 and 16.8). However, the difference between strata was not statistically significant and no linear doseresponse effect emerged (Table 2) .
Discussion
This analysis provides further evidence that an alcohol intake X12 g/day decreases total IGF-I levels, compared to non-drinkers or low alcohol drinkers. Our findings on IGF-I are consistent with those reported by Lavigne et al. (2005) in postmenopausal women. We found, however, a reduction of IGFBP-3 of borderline statistical significance in women who usually consumed X12 g/day of alcohol, whereas Holmes et al. (2002) reported a direct significant association and other authors (Lavigne et al., 2004 (Lavigne et al., , 2005 a nonsignificant one. Our study also suggests that alcohol consumption is associated with an increase in adiponectin levels, in agreement with results in middle-aged men (Sierksma et al., 2004) and in women (Thamer et al., 2004) . Alcohol, IGF system and adiponectin L Dal Maso et al Several factors may influence circulating concentrations of IGFs and adiponectin. IGF-I concentration varies across the menstrual cycle, but a controlled crossover feeding study of 37 premenopausal women showed that alcohol intake of 30 g/day decreased IGF-I concentration in all the phases of the menstrual cycle (Maskarinec et al., 2005) . IGF-I levels were negatively related to age and consistently higher in studies including younger women (Lavigne et al., 2004) . On the other hand, adiponectin was positively correlated with age and negatively with BMI (Maskarinec et al., 2005) . In this analysis, however, the exclusion of 28 pre-/perimenopausal women did not materially modify the results, and our estimates of IGFs concentration and adiponectin were in good agreement with previous papers (Goodman-Gruen and Barrett-Connor, 1997; Holmes et al., 2002; Cnop et al., 2003; Lavigne et al., 2005) . Other finer stratification is difficult because of the relatively small sample size of our study.
Adiponectin gene transcription is increased after stimulation with IGF-I, suggesting a possible direct association between IGF-I and adiponectin (Stefan and Stumvoll, 2002) . However, a case-control study conducted in Greece (Petridou et al., 2003) found only poor correlations between adiponectin and IGFs. Our data are in agreement with the Greek study and correlations between adiponectin and any IGFs where below |0.20|. These findings support the independency of adiponectin from the IGF system, and suggest the possibility that adiponectin and IGFs play different regulatory roles on insulin resistance, metabolism, body size and chronic diseases (Petridou et al., 2003; Augustin et al., 2004; Dal Maso et al., 2004a ).
An inter-individual wide range of IGFs values and adiponectin emerged in the present and in other studies (Kaklamani et al., 1999; Stefan and Stumvoll, 2002; Petridou et al., 2003) and a wide variability emerged for the same variables across published studies, mainly due to the different assays used (Dal Maso et al., 2004a) .
Problems of reliability in the reporting of alcohol drinking cannot be completely ruled out. This would have created misclassification depressing the effect estimated towards the null. However, this effect seems unlikely in our study as our questionnaire showed a satisfactory validity and reproducibility for alcohol consumption, and alcohol drinking is not stigmatized in our study areas (Ferraroni et al., 1996) .
A possible limitation of the study is the range of interindividual fluctuation of several IGF components, in particular IGFBP-1. The main strength is represented by the possibility of evaluating the amount of adiponectin and several circulating IGF components in women reporting no alcohol use lifelong or reporting a wide range of alcohol consumption.
In conclusion, our study indicates that alcohol consumption is related to circulating levels of IGF system components and adiponectin. As these results may have a potential impact on the prevention of several chronic diseases (Moschos and Mantzoros, 2002; Dal Maso et al., 2004a; Maskarinec et al., 2005) , additional large-scale population based studies are needed.
